Session Information
-
WCLC 2017
18th World Conference on Lung Cancer
Conference Program for the 18th World Conference on Lung Cancer in Yokohama, Japan
Download PDF of the Conference Program: Click Here.
Onsite Conference Program Addendum (17/10/2017): Click Here.
Download PDF of the Abstract Book: Click Here.
Financial Disclosure Summary (PDF): Click Here.Presentation Date(s):- Oct 15 - 18, 2017
- Total Presentations: 2295
October 14 Sat
Oct 14 Sunday
October 15 Sun
Oct 15 Monday
October 16 Mon
Oct 16 Tuesday
October 17 Tue
Oct 17 Wednesday
October 18 Wed
Oct 18
-
+
MTE 21 - Search for Novel Driver Mutations (Sign Up Required)
- 07:00 - 08:00
- 10/17/2017
- Location: Room 315
- Type: Meet the Expert
- Track: Chemotherapy/Targeted Therapy
-
+
MTE 21.01 - Novel Driver Mutations for Lung Cancer
07:00 - 07:30 | Presenter: Koichi Goto
- Abstract
No abstract available for this presentation
-
+
MTE 21.02 - New Molecular Diagnosis Platforms for Clinicians
07:30 - 08:00 | Presenter: Marc Ladanyi
- Abstract
No abstract available for this presentation
-
+
SH 01 - WCLC 2017 Highlights of the Previous Day
- 07:00 - 08:00
- 10/17/2017
- Location: Room 502
- Type: Scientific Highlights
- Track: Advanced NSCLC
-
+
SH 01.01 - Advanced NSCLC, Clinical Design, Statistics and Clinical Trials, Immunology and Immunotherapy and Patient Advocacy
07:00 - 07:20 | Presenter: Suresh S Ramalingam
- Abstract
No abstract available for this presentation
-
+
SH 01.02 - Surgery
07:20 - 07:40 | Presenter: Masafumi Kawamura
- Abstract
No abstract available for this presentation
-
+
SH 01.03 - Biology/Pathology and Epidemiology/Primary Prevention/Tobacco Control and Cessation
07:40 - 08:00 | Presenter: Y. Takiguchi
- Abstract
No abstract available for this presentation
-
+
SH 02 - WCLC 2017 Highlights of the Previous Day
- 07:00 - 08:00
- 10/17/2017
- Location: Room 503
- Type: Scientific Highlights
- Track: Biology/Pathology
-
+
SH 02.01 - Chemotherapy/Targeted Therapy and SCLC/Neuroendocrine Tumors
07:00 - 07:20 | Presenter: Robert Pirker
- Abstract
No abstract available for this presentation
-
+
SH 02.02 - Radiotherapy
07:20 - 07:40 | Presenter: Sung-Ja Ahn
- Abstract
No abstract available for this presentation
-
+
SH 02.03 - Biology/Pathology, Mesothelioma and Thymic Malignancies/Esophageal Cancer/Other Thoracic Malignancies
07:40 - 08:00 | Presenter: Yuko Minami
- Abstract
No abstract available for this presentation
-
+
PL 02 - Presidential Symposium including Top 3 Abstracts and James Cox Lectureship Award Presentation
- 08:15 - 09:45
- 10/17/2017
- Location: Plenary Hall (Exhibit Hall D)
- Type: Plenary Session
- Track: Early Stage NSCLC
- Moderators:Hisao Asamura, Keunchil Park
-
+
PL 02.01 - Introduction and Welcome
08:15 - 08:20
- Abstract
No abstract available for this presentation
-
+
PL 02.02 - Patient-Reported Outcomes with Durvalumab after Chemoradiation in Locally Advanced, Unresectable NSCLC: Data from PACIFIC
08:20 - 08:30 | Presenter: R. Hui | Author(s): M. Özgüroğlu, D. Daniel, D.V. Baz, S. Murakami, T. Yokoi, A. Chiappori, K.H. Lee, M. De Wit, B. Chul Cho, J.E. Gray, A. Rydén, L. Viviers, L. Poole, P.A. Dennis, S.J. Antonia
- Abstract
Loading... -
+
PL 02.03 - Discussant - PL 02.02
08:30 - 08:40 | Presenter: Michael Boyer
- Abstract
No abstract available for this presentation
-
+
PL 02.04 - SCAT Ph III Trial: Adjuvant CT Based on BRCA1 Levels in NSCLC N+ Resected Patients. Final Survival Results a Spanish Lung Cancer Group Trial
08:40 - 08:50 | Presenter: Bartomeu Massuti | Author(s): Manuel Cobo Dols, M. Rodriguez-Paniagua, I. Ballesteros, T. Morán, R. Arrabal, J.L. González-Larriba, I. Barneto, Y.W. Pun, J. De Castro, S. Ponce Aix, C. Baamonde, M.A. Muñoz, G. López-Vivanco, J.J. Rivas De Andrés, D. Isla, R. López, José Miguel Sánchez-Torres, J. Sánchez Paya, Rafael Rosell
- Abstract
Loading... -
+
PL 02.05 - Discussant - PL 02.04
08:50 - 09:00 | Presenter: Joan Schiller
- Abstract
No abstract available for this presentation
-
+
PL 02.06 - The IASLC Lung Cancer Staging Project: Analysis of Resection Margin Status and Proposals for R Status Descriptors for Non-Small Cell Lung Cancer
09:00 - 09:10 | Presenter: John G Edwards | Author(s): K. Chansky, L. Shemanski, Paul Emile Van Schil, Hisao Asamura, Ramon Rami-Porta
- Abstract
Loading... -
+
PL 02.07 - Discussant - PL 02.06
09:10 - 09:20 | Presenter: Kemp Kernstine
- Abstract
No abstract available for this presentation
-
+
PL 02.08 - James Cox Lectureship Award Presentation
09:20 - 09:45 | Presenter: James D. Cox
- Abstract
No abstract available for this presentation
-
+
P2.01 - Advanced NSCLC
- 09:00 - 16:00
- 10/17/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Advanced NSCLC
-
+
P2.01-001 - Serum Albumin Level Predicts the Survival Benefit of Chemotherapy in Elderly Advanced NSCLC Patients with Poor Performance Status
09:00 - 09:00 | Presenter: Satoshi Ikeda | Author(s): H. Yoshioka, S. Ikeo, M. Morita, N. Sone, T. Niwa, A. Nishiyama, T. Yokoyama, A. Sekine, T. Ogura, T. Ishida
- Abstract
Loading... -
+
P2.01-002 - Survival of Patients with Advanced Non-Small Cell Lung Cancer at Single Institute in Eastern Thailand, 2013-2016
09:00 - 09:00 | Presenter: Sitthi Sukauichai | Author(s): C. Tovanabutra, K. Chomprasert, S. Wanglikitkoon
- Abstract
Loading... -
+
P2.01-003 - Does Astragalus Membranaceus Root Extract Have Any Survival Benefit for Metastatic Non-Small Cell Lung Cancer?
09:00 - 09:00 | Presenter: Adnan Aydiner | Author(s): R. Ciftci
- Abstract
Loading... -
+
P2.01-004 - Safety and Efficacy of Nab-Paclitaxel plus Carboplatin in Elderly Patients with NSCLC (ABOUND.70+)
09:00 - 09:00 | Presenter: Corey J Langer | Author(s): E.C. Anderson, R.M. Jotte, Jonathan W. Goldman, D.E. Haggstrom, D.A. Smith, C.S.R. Dakhil, K. Konduri, E. Kim, T.J. Ong, A. Sanford, K.I. Amiri, J. Weiss
- Abstract
Loading... -
+
P2.01-005 - A Randomized Phase II Trial of Erlotinib vs S-1 in Patients with NSCLC as Third- or Fourth-Line Therapy (HOT1002)
09:00 - 09:00 | Presenter: Yasutaka Kawai | Author(s): H. Asahina, Y. Ikezawa, S. Oizumi, T. Ogi, M. Watanabe, T. Amano, H. Dosaka-Akita, H. Isobe, M. Nishimura
- Abstract
Loading... -
+
P2.01-006 - Effect of Maintenance Using Pemetrexed with and without Bevacizumad in Patients Advanced Lung Cancer in Non-Small Cells
09:00 - 09:00 | Presenter: Mayra Galeana Hernandez | Author(s): M. Magallanes Maciel
- Abstract
Loading... -
+
P2.01-007 - Molecular Characterization of Non-Small Cell Lung Cancers (NSCLC) in Young Patients from an Argentine Population
09:00 - 09:00 | Presenter: Valeria Cecilia Denninghoff | Author(s): G.J. Recondo, M.T. Cuello, M.M. García Falcone, V. Romano, M. Greco, V. Wainsztein, F. Galanternik, M. De La Vega, E. Rojas Bilbao, M.A. Avagnina, G. Recondo
- Abstract
Loading... -
+
P2.01-008 - Combination of Bavacizumab with Conventional Chemotherapy Shows Better Prognosis in Patients with Lung Cancer with Liver Metastasis
09:00 - 09:00 | Presenter: Kim Ki-Up | Author(s): C. Sung Jun, K. So-Mye
- Abstract
Loading... -
+
P2.01-009 - The Efficacy of Bevacizumab Adding in Standard First Line Chemotherapy and Maintenance Treatment in Advanced NSCLC: A Network Meta-Analysis
09:00 - 09:00 | Presenter: Voralak Vichapat | Author(s): Thanyanan Reungwetwattana, A. Thakkinstian
- Abstract
Loading... -
+
P2.01-010 - Risk Score for Predicting Acute Exacerbation after Chemotherapy in Lung Cancer Associated with Interstitial Pneumonia
09:00 - 09:00 | Presenter: Kazutoshi Isobe | Author(s): K. Kaburaki, Hiroshi Kobayashi, G. Sano, K. Sugino, S. Sakamoto, Y. Takai, Takashi Makino, N. Tochigi, Akira Iyoda, S. Homma
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P2.01-012 - Impact of Brain Metastases on the Humanistic Burden Incurred by Patients with Advanced Non-small Cell Lung Cancer (A-nsclc)
09:00 - 09:00 | Presenter: Oana Chirita | Author(s): G. Taylor-Stokes, R. Wood, M. Lees
- Abstract
Loading... -
+
P2.01-013 - Nab-Paclitaxel/Carboplatin in Elderly Patients with NSCLC (ABOUND.70+): Analysis of Safety and Quality of Life (QoL) by Cycle
09:00 - 09:00 | Presenter: Corey J Langer | Author(s): E. Kim, J. Weiss, E.C. Anderson, R.M. Jotte, Jonathan W. Goldman, D.E. Haggstrom, D.A. Smith, C.S.R. Dakhil, K. Konduri, T. Berry, T.J. Ong, A. Sanford, K.I. Amiri
- Abstract
Loading... -
+
P2.01-014 - ABOUND.PS2: Safety and Efficacy of Nab-Paclitaxel–Based Therapy in Patients with NSCLC and ECOG PS 2
09:00 - 09:00 | Presenter: Ajeet Gajra | Author(s): N. Abdel Karim, D.A. Mulford, M.R. Matrana, H.Y. Ali, Edgardo S. Santos, T.J. Ong, A. Sanford, K.I. Amiri, David R Spigel
- Abstract
Loading... -
+
P2.01-015 - Longitudinal Assessment of Performance Status (PS) in Patients with NSCLC and ECOG PS 2 on Nab-Paclitaxel–Based Therapy
09:00 - 09:00 | Presenter: Nagla Abdel Karim | Author(s): D.A. Mulford, M.R. Matrana, H.Y. Ali, Edgardo S. Santos, T.J. Ong, A. Sanford, K.I. Amiri, David R Spigel, Ajeet Gajra
- Abstract
Loading... -
+
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P2.01-018 - Risk Factors in Patients with Pathological N1 or N2 Non-Small Cell Lung Cancer
09:00 - 09:00 | Presenter: Yoshimasa Tokunaga | Author(s): T. Okamoto, Y. Kita
- Abstract
Loading... -
+
P2.01-019 - The Necessity of Contrast-enhanced CT before CT-Guided Percutaneous Transthoracic Needle Biopsy for Lung Lesions
09:00 - 09:00 | Presenter: Tang Feng Lv | Author(s): H. Hu, H. Liu, Yong Song
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P2.01-021 - Efficacy of Single-Agent Chemotherapy after Exposure to Nivolumab in Advanced Non-Small Cell Lung Cancer
09:00 - 09:00 | Presenter: Yuto Yasuda | Author(s): Tomoko Funazo, T. Nomizo, T. Tsuji, Hironori Yoshida, Yuichi Sakamori, H. Nagai, H. Ozasa, T. Hirai, Y.H. Kim
- Abstract
Loading... -
+
P2.01-022 - Nintedanib/Docetaxel Efficacy in Advanced Lung Adenocarcinoma Treated with 1L Chemotherapy/2L Immunotherapy in Nintedanib NPU
09:00 - 09:00 | Presenter: Jesus Corral | Author(s): Margarita Majem, D. Rodríguez-Abreu, Enric Carcereny, Angel Artal Cortes, M. Llorente, J.M. López Picazo, Y. García, M. Domine, M.P. Lopez Criado
- Abstract
Loading... -
+
P2.01-023 - Reasons for Withholding Systemic Therapy in Stage IV NSCLC: Comparison of Years 2004 to 2007 and 2010 to 2013
09:00 - 09:00 | Presenter: Gouri Shankar Bhattacharyya | Author(s): H. Malhotra, K. Govindbabu, G. Biswas, A. Vora, T. Shahid
- Abstract
Loading... -
+
P2.01-024 - Prognostic Value of Body Fat Mass Ratio in Lung Cancer Patients
09:00 - 09:00 | Presenter: Abdurrahman ?sikdogan | Author(s): N. Akdeniz, A. Akbay, Z. Oruc, M.A. Kaplan
- Abstract
Loading... -
+
P2.01-025 - Evaluation of Calculating Carboplatin Dosage in Carboplatin–Pemetrexed Therapy in Chinese Patients with Advanced NSCLC
09:00 - 09:00 | Presenter: Yixiang Zhu | Author(s): P. Xing, J. Li
- Abstract
Loading... -
+
P2.01-026 - Distribution of Metastatic Disease in Survival Outliers with Stage IV Non-Small Cell Lung Cancer
09:00 - 09:00 | Presenter: D. Gwyn Bebb | Author(s): A. Fung, A. D'Silva, H. Li, S. Otsuka
- Abstract
Loading... -
+
P2.01-027 - Clinical Significance of Topoisomerase-II Expression in Patients with Non-Small Cell Lung Cancer Treated with Amrubicin
09:00 - 09:00 | Presenter: Reiko Sakurai | Author(s): K. Kaira, Yosuke Miura, Y. Tomizawa, Y. Tsukagoshi, T. Masuda, Norimitsu Kasahara, N. Sunaga, R. Saito, T. Hisada
- Abstract
Loading... -
+
P2.01-028 - Clinical Correlation between CTCs Enumeration Based on New Detection Method and Chemotherapy Efficacy in Human Advanced Lung Cancer
09:00 - 09:00 | Presenter: Honglei Chen | Author(s): H. Chen, C. Zhao
- Abstract
Loading... -
+
P2.01-029 - Real World Report of Clinical Outcomes of Bevacizumab in First-Line or Later-Line Treatment for Patients with Advanced NSCLC
09:00 - 09:00 | Presenter: Yalei Wang | Author(s): X. Hao, Yixiang Zhu, X. Hu, H. Wang, Y. Liu, Yuxin Mu, Junling Li, Y. Wen, Y. Wang
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P2.01-031 - Use of Geriatric Assessment (GA) in Clinical Practice for Stage IV Non-Small Cell Lung Cancer (NSCLC). The GIDO Experience
09:00 - 09:00 | Presenter: Regina Gironés | Author(s): F. Aparisi, A. Sánchez, J. García, Ó. Juan
- Abstract
Loading... -
+
P2.01-032 - A Randomized Phase Ii Trial of Selumetinib + Platinum-pemetrexed (Pem-c) in Kras Wildtype (Wt)/Unknown NSCLC: CCTG Ind219
09:00 - 09:00 | Presenter: Barbara Melosky | Author(s): Penelope Bradbury, D. Tu, G. Nicholas, P. Wheatley-Price, S.A. Laurie, Glenwood Goss, M. Florescu, N. Basappa, A. Reiman, A. Tan, Desiree Hao, J. Rotherstein, Natasha B Leighl, John R Goffin, C. Kollmannsberger, P. Kaurah, P. Brown-Walker, L. Seymour
- Abstract
Loading... -
+
P2.01-033 - Leptomeningeal Metastasis from Non-Small Cell Lung Cancer: A Single Center Experience in Chinese Patients
09:00 - 09:00 | Presenter: Junling Li | Author(s): X. Wu, L. Yu, Y.B. Yang
- Abstract
Loading... -
+
P2.01-034 - Phase I/II Trial of Weekly Nab-Paclitaxel as 2nd or 3rd Line Treatment in NSCLC Without Driver Mutations. (OLCSG1303)
09:00 - 09:00 | Presenter: Kenichiro Kudo | Author(s): Shoichi Kuyama, Daijiro Harada, T. Kozuki, A. Bessho, K. Hotta, H. Yoshioka, K. Gemba, N. Takigawa, I. Oze, K. Kiura
- Abstract
Loading... -
+
P2.01-035 - Phase II Study: Weekly Docetaxel as First Line Chemotherapy for Elderly Patients with Squamous-Cell Non-Small-Cell Lung Cancer
09:00 - 09:00 | Presenter: Kyung Ho Kang | Author(s): Sung Yong Lee, J.H. Choi, S.M. Chung, J.Y. Oh, Y.S. Lee, K.H. Min, G.Y. Hur, J.J. Shim, H.K. Lee
- Abstract
Loading... -
+
P2.01-036 - Symptom Trajectories During Chemotherapy Predict Overall Survival in Patients with Advanced Non-Small Cell Lung Cancer
09:00 - 09:00 | Presenter: Qiuling Shi | Author(s): X.S. Wang, L.A. Williams, T.R. Mendoza, George R. Simon, C.S. Cleeland
- Abstract
Loading... -
+
P2.01-037 - Clinical Impact of Interstitial Lung Disease on Advanced Non-Small Cell Lung Cancer
09:00 - 09:00 | Presenter: Hajime Oi | Author(s): H. Taniguchi, Y. Kondoh, Tomoki Kimura, K. Kataoka, T. Matsuda, T. Yokoyama
- Abstract
Loading... -
+
P2.01-038 - Determinants of Frailty and Treatment Toxicity in Non-Small Cell Lung Cancer Patient
09:00 - 09:00 | Presenter: Marie-Eve Boucher | Author(s): Laura Mezquita, E. Auclin, M. Mons, J. Marghadi, M. Charrier, Roberto Ferrara, David Planchard, G. Anas, Cecile Le Pechoux, Angela Botticella, C. Caramella, J. Adam, J. Soria, Benjamin Besse
- Abstract
Loading... -
+
P2.01-039 - Erythropoiesis-Stimulating Agents for Chemotherapy-Induced Anaemia in Lung Cancer: Efficacy, Toxicity and Effect on Survival
09:00 - 09:00 | Presenter: Kostas Syrigos | Author(s): V. Xirou, I. Gkiozos, D. Grapsa, Ioannis Dimitroulis
- Abstract
Loading... -
+
P2.01-040 - Pemetrexed plus Platinum Chemotherapy with or Without Immunotherapy in Non-Squamous NSCLC: Descriptive Safety Analysis
09:00 - 09:00 | Presenter: Vassiliki A Papadimitrakopoulou | Author(s): Ramaswamy Govindan, Hossein Borghaei, S. He, J.S. Kim
- Abstract
Loading... -
+
P2.01-041 - Pemetrexed plus Platinum Chemotherapy with or Without ImmunoResponses of Bevacizumab plus Cisplatin for the Non-Squamous Non-Small-Cell Lung Cancer Patients with Malignant Pleural Effusionstherapy in Non-Squamous NSCLC: Descriptive Safety Analysis
- Abstract
Loading... -
+
P2.01-042 - Perioperative Chemotherapy with Pemetrexed and Cisplatin for Pulmonary LCNEC: A Case Report and Literature Review
09:00 - 09:00 | Presenter: Hong Tang
- Abstract
Loading... -
+
P2.01-043 - PD-L1 Expression, EGFR and KRAS Mutations in First-Line Therapy (1L) for Non-Small Cell Lung Cancer (NSCLC) Patients
09:00 - 09:00 | Presenter: James Rigas | Author(s): D. Cronin-Fenton, T. Dalvi, E. Hedgeman, M. Norgaard, L. Petersen, H. Hansen, J. Fryzek, D. Lawrence, J. Walker, A. Mellemgaard, T. Rasmussen, N. Shire, D. Potter, S. Hamilton-Dutoit, H. Sorensen
- Abstract
Loading... -
+
P2.01-044 - The Correlation Between One Year Survival and the Affecting Factors of Lung Cancer Patients at Dr. Moewardi Hospital Surakarta
09:00 - 09:00 | Presenter: Ana Rima | Author(s): H.N. Mayasari, S. Sunarso, Y.S. Sutanto
- Abstract
Loading... -
+
P2.01-045 - The Efficiency of Apatinib plus S-1 as Laterline Chemotherapy for Advanced Non-Small-Cell Lung Cancer
09:00 - 09:00 | Presenter: Zhiyong Wu | Author(s): G. Dai, J. Wu, Y. Wang
- Abstract
Loading... -
+
P2.01-046 - Clinical Characteristics of Survival with De Novo Versus Relapsed Metastatic Non-Small Cell Lung Cancer
09:00 - 09:00 | Presenter: Gwyn Bebb | Author(s): A.J.W. Gibson, H. Li, A. D'Silva, R.A. Tudor, A.A. Elegbede, S. Otsuka, W. Cheung
- Abstract
Loading... -
+
P2.01-047 - A Phase 1 Trial of Dose Escalated BGB324 in Combination with Docetaxel for Previously Treated Advanced NSCLC
09:00 - 09:00 | Presenter: David E Gerber | Author(s): P. Levin, F. Fattah, R.A. Brekken, P. Currykosky, J. Padro, M. Yule, K. Wnuk-Lipinska, E.M. Nævdal, A. Boniecka, G. Gausdal, J. Lorens
- Abstract
Loading... -
+
P2.01-048 - Early Changes in Body Composition in Metastatic Non-Small Cell Lung Cancer (NSCLC) Are Predictive for Poor Overall Survival
09:00 - 09:00 | Presenter: Anne-Marie C. Dingemans | Author(s): J.H.R.J. Degens, K.J.C. Sanders, E.E.C. De Jong, A.M.W.J. Schols
- Abstract
Loading... -
+
P2.01-049 - Long Progression Free Survival and Overall Survival in Advanced NSCLC Patients with EGFR Mutation and Complete Response with TKI Treatment
09:00 - 09:00 | Presenter: Omar Macedo-Pérez | Author(s): I. Lyra-González, D.B. Marroquín-Flores, G. Cruz-Rico, L.A. Ramírez-Tirado, L. Valdez-Rojas, A. Tabares-Nañez, J.E. Gonzales-Nogales, Oscar Arrieta
- Abstract
Loading... -
+
P2.01-050 - Predicting Risk of Hospitalization in Patients with NSCLC Receiving Chemotherapy Using the LCSS 3-Item Global Index (3-IGI)
09:00 - 09:00 | Presenter: Richard J Gralla | Author(s): Patricia J. Hollen, N. Gaspe, R. Hall, R. Genzler, H. Cordero, Haiying Cheng, J. Gildersleeve, Jeffrey Crawford, L. Rosen, M. Lesser
- Abstract
Loading... -
+
P2.01-051 - Randomized Study of Pemetrexed Versus Erlotinib as Maintenance Therapy in Metastatic /Locally Advanced EGFR Mutation Negative NSCLC
09:00 - 09:00 | Presenter: Vikas Talreja | Author(s): A. Joshi, V. Noronha, V. Patil, M. Sharma, C. Vora, S. Goud, S. More, S. Shah, A. Mahajan, A. Janu, R. Kaushal, K. Prabhash
- Abstract
Loading... -
+
P2.01-052 - Does Radiomics Improves the Survival Prediction in Non Small Cell Lung Cancer?
09:00 - 09:00 | Presenter: Ravindra Patil | Author(s): G. M, L. Wee, A. Dekker
- Abstract
Loading... -
+
P2.01-053 - Outcome of Clinical Management of Elderly and Younger Patients with NSCLC Inside a Private Institution (Oncosalud-AUNA)
09:00 - 09:00 | Presenter: Jose Maria Gutierrez Castañeda | Author(s): Claudio Flores, R. Ruiz Mendoza, L.A. Mas Lopez, A. Aguilar, C. Vallejos, L. Pinillos-Ashton
- Abstract
Loading... -
+
P2.01-054 - Inclusion of Central Nervous System Metastasis in Lung Cancer Early Phase Clinical Trials
09:00 - 09:00 | Presenter: Narjust Duma | Author(s): M. Gonzalez Velez, V. Mariotti, R. Carr, Erin Schenk, K. Leventakos, J. Molina, Aaron S. Mansfield, Alex Adjei
- Abstract
Loading... -
+
P2.01-055 - Examining Metabolomics as a Prognostic Marker in Metastatic Non–Small Cell Lung Cancer Patients Undergoing First-Line Chemotherapy
09:00 - 09:00 | Presenter: Desiree Hao | Author(s): A. Sengupta, K. Ding, Natasha B Leighl, Frances A Shepherd, L. Seymour, A. Weljie
- Abstract
Loading... -
+
P2.01-056 - Use of Cell-Free Circulating RNA (cfRNA) Expression of PD-L1 and ERCC1 in Plasma to Monitor Response to Therapy in NSCLC
09:00 - 09:00 | Presenter: Luis E Raez | Author(s): K. Danenberg, A.B. Castrellon, S. Rabizadeh, J. Usher, Y. Jaimes, B. Hunis, Martin Frederik Dietrich, C. Habaue, P. Danenberg
- Abstract
Loading... -
+
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P2.01-058a - Dose Serum Lactate Dehydrogenase Have a Significant Prognostic Value in Lung Cancer?
09:00 - 09:00 | Presenter: Sharareh Seifi | Author(s): A. Khosravi, Z. Esfahani-Monfared, B. Salimi
- Abstract
No abstract available for this presentation
-
+
P2.01-059 - Breast Metastasis from Pulmonary Cancer: A Case Report. University Hospital "Shefqet Ndroqi" Tirana Albania 2008
09:00 - 09:00 | Presenter: Fadil Gradica | Author(s): D. Argjiri, L. Lisha, I. Avdiu, G. Cerga, A. Lala, F. Kokici, A. Cani, A. Kalenja, L. Zhegu
- Abstract
Loading... -
+
P2.01-060 - Outcomes Following Gamma Knife Radiosurgery in Patients with Non-Small Cell Lung Cancer with Brain Metastases
09:00 - 09:00 | Presenter: Oliver Coen | Author(s): S. El Badri, P. Hatfield, K.N. Franks, P. Jain, M. Snee, Katy Louise Clarke
- Abstract
Loading... -
+
P2.01-061 - Mode of Lung and Airway Metastasis of NSCLC: Review of Chest CT Findings
09:00 - 09:00 | Presenter: Mi Young Kim | Author(s): Jae Cheol Lee, H.R. Kim, H.J. Koo
- Abstract
Loading... -
+
P2.01-062 - Primary Lung Adenocarcinoma in the Young with Multiple Metastases: An Autopsy Report of 2 Cases
09:00 - 09:00 | Presenter: Randell Santos Arias | Author(s): F.S. Templo, Jr., L.C. Subia, O.P.R. Balisan
- Abstract
Loading... -
+
P2.01-063 - Outcomes of Patients with Oligometastatic Non-Small Cell Lung Cancer Who Were Treated with Radical Treatment
09:00 - 09:00 | Presenter: Ahmet Bilici | Author(s): F. Selcukbiricik, R. Rzazade, O.F. Olmez, H.B. Caglar, O. Yildiz
- Abstract
Loading... -
+
P2.01-064 - Co-Existing Mutations and Their Clinical Implications in Non-Small Cell Lung Cancer: Korean Lung Cancer Consortium (KLCC-13-01)
09:00 - 09:00 | Presenter: Bo Mi Ku | Author(s): N.L. Lee, M.S. Kim, Jong-Mu Sun, S. Lee, Jin Seok Ahn, Keunchil Park, Myung-Ju Ahn
- Abstract
Loading... -
+
P2.01-065 - Clinico-Radiological and Pathological Evaluation of Lung Adenocarcinoma with Infiltration on the Computed Tomography of the Chest
09:00 - 09:00 | Presenter: Asuka Okada | Author(s): S. Choh, T. Nakai, C. Ohbayashi, Y. Kurono, M. Ueda, K. Katayama, N. Koguchi, S. Murakami, H. Takenaka
- Abstract
Loading... -
+
P2.01-066 - Targeted Therapy for Lung Cancer: Liquid Biopsy or Tumor Sampling? A Case-Control Study
09:00 - 09:00 | Presenter: Zhen-Yu Ding | Author(s): C. Wang
- Abstract
Loading... -
+
P2.01-067 - Treatment of the Patients with Oncological Emergencies with Massive Pleural Effusion at the First Hospital Visit
09:00 - 09:00 | Presenter: Kazuhiro Ito | Author(s): Junichi Shimada, D. Kato, M. Inoue
- Abstract
Loading... -
+
P2.01-068 - Lobectomy Improve the Survival of Non-Small Cell Lung Cancer Patients with Occult Malignant Pleural Disease First Detected at Thoracotomy
09:00 - 09:00 | Presenter: Shaolei Li | Author(s): S. Zhang, Miao Huang, Y. Ma, Y. Yang
- Abstract
Loading... -
+
P2.01-069 - Radiologists' Considerations to Determine the Origin of Tumor on Chest CT: Lung vs Mediastinum
09:00 - 09:00 | Presenter: Junghwa Choi | Author(s): S. Song
- Abstract
Loading... -
+
P2.01-070 - FAACT- Anorexia Cachexia Scale: Cut-Off Value for the Anorexia Diagnosis in NSCLC Patients
09:00 - 09:00 | Presenter: Jenny Turcott | Author(s): L. Ramirez-Tirado, L.F. Oñate-Ocaña, D. Flores-Estrada, Z.L. Zatarain-Barron, G. Soca-Chafre, Oscar Arrieta
- Abstract
Loading... -
+
P2.01-071 - Efficacy of Thoracic Radiotherapy in Oligometastatic Non-Small-Cell Lung Cancer Harboring Wild-Type EGFR After First-Line Chemotherapy
09:00 - 09:00 | Presenter: Congying Xie | Author(s): B. Lin, Xiance Jin
- Abstract
Loading... -
+
P2.01-072 - Local Management of Oligometastasis in Non-Small Cell Lung Cancer (NSCLC)
09:00 - 09:00 | Presenter: Margarita Majem Tarruella | Author(s): M. Riudavets Melia, L.P. Del Carpio Huerta, A. Barba Joaquín, G. Anguera Palacios, I.G. Sullivan, A. Callejo Perez, N. Farré, A. Torrego, V. Pajares, E. Martínez, J.C. Trujillo, C. De Quinana
- Abstract
Loading... -
+
P2.01-073 - Prognostic Factors Analysis of Non-Small Cell Lung Cancer with Brain Metastases
09:00 - 09:00 | Presenter: Jiancheng Li | Author(s): Y. Xue
- Abstract
Loading... -
+
P2.01-074 - Wait and See: A Favorable Alternative for R-M1a and S-M1a NSCLC Patients
09:00 - 09:00 | Presenter: Ying Chen
- Abstract
Loading... -
+
P2.01-075 - Genomic Changes and Clinical Characteristics Associated with Wood-Smoke Exposure in Patients with Non-Small Cell Lung Cancer
09:00 - 09:00 | Presenter: Norma Yanet Hernandez-Pedro | Author(s): G. Soca-Chafre, C. Alaez, K. Carrillo-Sanchez, P. Barrios-Bernal, Oscar Arrieta
- Abstract
Loading... -
+
- Abstract
No abstract available for this presentation
-
+
P2.01-075b - Analysis of the Safety and Usefulness of Nab-Paclitaxel Therapy in Patients with Non-Small Cell Carcinoma
09:00 - 09:00 | Presenter: I. Eriko
- Abstract
Loading... -
+
P2.01-075c - FGFR1 as an Intrinsic Resistance Mechanism in Erlotinib Treated EGFR Mutated NSCLC
09:00 - 09:00 | Presenter: Kristine Raaby Jakobsen | Author(s): J. Vad-Nielsen, S. Weiss, M.S. Clement, T.F. Daugaard, B.S. Soerensen, A.L. Nielsen
- Abstract
Loading... -
+
P2.01-075d - Analysis of Early Survival in Patients with Advanced Non-Squamous NSCLC Treated with Nivolumab: The Italian Expanded Access Program Experience
09:00 - 09:00 | Presenter: Hector Josè Soto Parra | Author(s): E. Defraia, D. Pozzessere, A. Bettini, A. Scoppola, A. Pazzola, A. Bertolini, P. Tagliaferri, P.F. Conte, G. Surico, A. Berruti, M. Minelli, A. Santo, E.M. Ruggeri, G. Cartenì, M. Pagano, F. Verderame, F. Roila, A. Del Monte, M. Tiseo
- Abstract
Loading... -
+
P2.01-075e - Neutrophil to Lymphocyte Ratio Predicts Survival in Advanced NSCLC Patients Treated with Second-Line PD-1 Immune Checkpoint Inhibitors
09:00 - 09:00 | Presenter: Philip Bonomi | Author(s): S. Labomascus, I. Fughhi, M.J. Fidler, J.A. Borgia, S. Basu, M. Hoch, M. Batus
- Abstract
No abstract available for this presentation
-
+
P2.01-075f - Detection of EML4-ALK and ROS1 Fusion Gene in NSCLC by PNA-Assisted Real-Time RT-PCR Using Fluorescent Meting Curve Analysis
09:00 - 09:00 | Presenter: Myosun Kim
- Abstract
Loading... -
+
P2.01-075g - Genotyping of EML4-ALK Fusion Gene by PNA-Assisted Real-Time RT-PCR Using Fluorescent Meting Curve Analysis
09:00 - 09:00 | Presenter: Myosun Kim
- Abstract
Loading...
-
+
P2.02 - Biology/Pathology
- 09:30 - 16:00
- 10/17/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Biology/Pathology
-
+
P2.02-001 - Detection of Gene Fusions in NSCLC Using NGS Fusion Assay
09:30 - 09:30 | Presenter: Yoon-La Choi | Author(s): M.E. Lira, Y.S. Choi, Seung Joon Kim, Y.M. Shim, O. Perez, Jhingook Kim
- Abstract
Loading... -
+
P2.02-002 - Digital Multiplexed Detection of Single Nucleotide Variants (SNV) in Non-Small Cell Lung Cancer Using NanoString Technology
09:30 - 09:30 | Presenter: Brielle Parris | Author(s): G. Meredith, P..M. Ross, M. Krouse, A. Mashadi-Hossein, R. Bowman, I. Yang, Kwun M Fong
- Abstract
Loading... -
+
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P2.02-005 - 13 Cases of Molecular Features Analysis in Pulmonary Mucoepidermoid Carcinoma
09:30 - 09:30 | Presenter: Gang Chen | Author(s): Chunwei Xu, W. Wang, Wu Zhuang, Z. Song, Y. Chen, Meiyu Fang, T.F. Lv, Yong Song
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P2.02-007 - Molecular Spectrum of STK11 Gene Mutations in Patients with Non-Small-Cell Lung Cancer in Chinese Patients
09:30 - 09:30 | Presenter: Gang Chen | Author(s): X. Chen, Chunwei Xu, W. Wang, Wu Zhuang, Z. Song, Y. Zhu, Y. Chen, Rongrong Chen, Y. Guan, X. Yi, Meiyu Fang, T.F. Lv, Yong Song
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P2.02-009 - Metabolomic Analysis in Lung Cancer
09:30 - 09:30 | Presenter: Naohiro Kajiwara | Author(s): S. Maehara, J. Maeda, M. Hagiwara, T. Okano, Masatoshi Kakihana, Tatsuo Ohira, M. Sugimoto, Norihiko Ikeda
- Abstract
Loading... -
+
P2.02-010 - Oncogenic Role of PKP1 in Non-Small-Cell Lung Cancer.
09:30 - 09:30 | Presenter: Pedro P Medina | Author(s): J. Martin-Padron, L. Boyero Corral, M.I. Rodriguez Lara, Á. Andrades Delgado, E. Farez-Vidal
- Abstract
Loading... -
+
P2.02-011 - Clinical and Molecular Features of Lung Cancers with Increased FGFR1 mRNA and/or Gene Copy Number
09:30 - 09:30 | Presenter: Terry L. Ng | Author(s): Hui Yu, E. York, S. Leedy, D. Gao, L. Heasley, Fred R. Hirsch, D. Ross Camidge
- Abstract
Loading... -
+
P2.02-012 - The Epigenetic Role of LSD1+8a in Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Aditya Wirawan | Author(s): K. Tajima, F. Takahashi, Moulid Hidayat, R. Kanemaru, Y. Koinuma, D. Hayakawa, M. Tajima, N. Matsumoto, K. Kanamori, I. Takeda, M. Kato, I. Kobayashi, N. Shimada, K. Takahashi
- Abstract
Loading... -
+
P2.02-013 - Investigation of Genomic and TCR Repertoire Evolution of AAH, AIS, MIA to Invasive Lung Adenocarcinoma by Multiregion Exome and TCR Sequencing
09:30 - 09:30 | Presenter: Jianjun Zhang | Author(s): X. Hu, J. Fujimoto, L. Ying, A. Reuben, R. Chen, C. Chow, J. Rodriguez-Canales, W. Sun, J. Hu, E.R. Parra, B. Carmen, C. Wu, X. Mao, X. Song, J. Li, C. Gumbs, S.G. Swisher, J. Zhang, John V Heymach, W.K. Hong, Ignacio I. Wistuba, A. Futreal, D. Su
- Abstract
Loading... -
+
P2.02-014 - Simultaneous Gene Profiling of Advanced NSCLC: Single-Molecule Quantification of DNA and RNA by nCounter3D™ Technology
09:30 - 09:30 | Presenter: Cristina Teixidó | Author(s): A. Giménez-Capitán, G. Meredith, D. Martinez, A. Mashadi-Hossein, C. Hernan, P..M. Ross, A. Arcocha, P. Galván, N. Vilariño, S. Lopez-Padres, S. Rodriguez, J. Bertran-Alamillo, A. Prat, Miguel-Angel Molina-Vila, Noemi Reguart
- Abstract
Loading... -
+
P2.02-015 - Mutation Patterns in a Swedish Non-Small Cell Lung Cancer Cohort
09:30 - 09:30 | Presenter: Linnea La Fleur | Author(s): E. Falk-Sörqvist, P. Smeds, Johanna Sofia Margareta Mattsson, M. Sundström, E. Branden, H. Koyi, J. Isaksson, H. Brunnström, M. Nilsson, Patrick Micke, L. Moens, J. Botling
- Abstract
Loading... -
+
P2.02-016 - Pulmonary Sarcomas: A Comprehensive Genomic Profiling Study
09:30 - 09:30 | Presenter: Jeffrey S. Ross | Author(s): J. Suh, Siraj M Ali, A.B. Schrock, J. Elvin, J. Vergilio, S. Ramkissoon, V.A. Miller, P.J. Stephens, L. Gay
- Abstract
Loading... -
+
P2.02-017 - Aberrant Expression of Long Non-Coding RNAs from Pseudogene Loci Highlights Alternative Mechanisms of Cancer Gene Regulation
09:30 - 09:30 | Presenter: Greg L. Stewart | Author(s): Katey S.S. Enfield, Victor D Martinez, Adam Patrick Sage, Erin Anne Marshall, Stephen Lam, W.L. Lam
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P2.02-019 - Utility of Circulating Tumor DNA (CtDNA) in Prognostication of Lung Cancer vs. Other Cancer Types
09:30 - 09:30 | Presenter: Francisco III Maramara Heralde | Author(s): Maria Teresa Alhambra Barzaga, N. Tan-Liu
- Abstract
Loading... -
+
P2.02-020 - Molecular Characteristics of Patients with PTEN Mutations in Chinese Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Meiyu Fang | Author(s): Xiaobing Zheng, Chunwei Xu, W. Wang, Wu Zhuang, Z. Song, Y. Zhu, Rongrong Chen, Y. Guan, X. Yi, Y. Chen, Gang Chen, T.F. Lv, Yong Song
- Abstract
Loading... -
+
P2.02-021 - Prevalence of PTPRD Gene Mutations in Chinese Non-Small Cell Lung Cancer Patients
09:30 - 09:30 | Presenter: Meiyu Fang | Author(s): S. Wang, Chunwei Xu, W. Wang, Wu Zhuang, Z. Song, Y. Zhu, Rongrong Chen, Y. Guan, X. Yi, Y. Chen, Gang Chen, T.F. Lv, Yong Song
- Abstract
Loading... -
+
P2.02-022 - Alternative Regulation of Cancer-Associated Genes through Modulation of Long Non-Coding RNAs
09:30 - 09:30 | Presenter: Adam Patrick Sage | Author(s): Greg L. Stewart, C. Anderson, D.A. Rowbotham, Katey S.S. Enfield, Erin Anne Marshall, Victor D Martinez, W.L. Lam
- Abstract
Loading... -
+
P2.02-023 - Targeted Gene Expression Profiling to Evaluate Minimal Diagnostic FFPE-Biopsies from NSCLC-Patients
09:30 - 09:30 | Presenter: Johanna Sofia Margareta Mattsson | Author(s): Victor Pontén, M.W. Backman, Patrick Micke
- Abstract
Loading... -
+
P2.02-024 - False Positivity Due to Polysomy in Fluorescence in Situ Hybridization
09:30 - 09:30 | Presenter: Erik Thunnissen | Author(s): A.L. Görtz, Stephen P Finn, Lukas Bubendorf, I. Bahce, B. Witte
- Abstract
Loading... -
+
P2.02-025 - Histological Difference of Tumor-Infiltrate Lymphocytes in Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Naohiro Kobayashi | Author(s): Shinji Kikuchi, Y. Goto, Y. Sato, S. Sakashita, M. Noguchi
- Abstract
Loading... -
+
P2.02-026 - Impact of PD-L1 Expression on 18F-FDG-PET in Pulmonary Squamous Cell Carcinoma
09:30 - 09:30 | Presenter: Norimitsu Kasahara | Author(s): K. Kaira, B. Alatan, T. Higuachi, Y. Arisaka, E. Bilguun, N. Sunaga, T. Oyama, T. Yokobori, T. Asao, M. Nishiyama, K. Shimizu, A. Mogi, H. Kuwano
- Abstract
Loading... -
+
P2.02-027 - Are Inflammatory Markers Predictive of Nivolumab Efficacy in Advanced Non-Small-Cell Lung Cancer (NSCLC)?
09:30 - 09:30 | Presenter: José Miguel Sánchez-Torres | Author(s): J. Rogado, M.D. Fenor De La Maza, V. Pacheco-Barcia, J.M. Serra, P. Toquero, B. Vera, A. Ballesteros, R. Mondéjar, O. Donnay, B. Obispo, R. Colomer
- Abstract
Loading... -
+
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P2.02-030 - Bavituximab in Combination With Nivolumab Enhances Tumor Immune Response in a 3D Ex Vivo System of Lung Cancer Patients
09:30 - 09:30 | Presenter: Joseph Shan | Author(s): M. Mediavilla-Varela, M.M. Page, J. Kreahling, B. Freimark, N.L. Kallinteris, S. Antonia, S. Altiok
- Abstract
Loading... -
+
P2.02-031 - Relationship between PD-L1 Expression and EGFR/HER2 Signaling in Non-Small-Cell Lung Cancer
09:30 - 09:30 | Presenter: Riki Okita | Author(s): A. Maeda, Katsuhiko Shimizu, Y. Nojima, S. Saisho, M. Nakata
- Abstract
Loading... -
+
P2.02-032 - Interplaying between Gamma-H2AX and Autophagy in A549 Cells Treated with Cisplatin and Etoposide
09:30 - 09:30 | Presenter: Jong Wook Shin | Author(s): S.E. Lee
- Abstract
Loading... -
+
P2.02-033 - The Association of PD-L1 Expression with Clinical Characteristics and EGFR and ALK Status in Lung Adenocarcinoma
09:30 - 09:30 | Presenter: Jinghui Wang | Author(s): S. Wu, Xiaohua Shi, Y. Liu, X. Zeng, L. Zhou
- Abstract
Loading... -
+
P2.02-034 - PD-L1 Expression Can Be a Prognostic Marker in EGFR Mutant NSCLC Patients Treated with Erlotinib
09:30 - 09:30 | Presenter: Niki Karachaliou | Author(s): Andrés F. Cardona, M. González Cao, A. Giménez-Capitán, A. Drozdowskyj, E. Aldeguer, G. López-Vivanco, José Miguel Sánchez-Torres, M. De Los Llanos Gil, Miguel-Angel Molina-Vila, Rafael Rosell
- Abstract
Loading... -
+
P2.02-035 - PD-L1 IHC Test on Cytological Cell Block Specimen; Potential Utility and Practical Issues
09:30 - 09:30 | Presenter: Michiko Sugiyama | Author(s): T. Hashimoto, K. Yoshida, Y. Shibuki, Shun-ichi Watanabe, N. Yamamoto, Yuichiro Ohe, N. Motoi
- Abstract
Loading... -
+
P2.02-036 - The Expression Pattern of CD26/DPP4 in Human Lung Cancer
09:30 - 09:30 | Presenter: Ignacio Gil-Bazo | Author(s): J. Jang, M. Haberecker, C. Alexandra, A. Soltermann, F. Janker, K. Kwon, Walter Weder, W. Jungraithmayr
- Abstract
Loading... -
+
P2.02-037 - CD14+ Cell Tumor Microenvironment Infiltration Correlates with Poor Overall Survival in Patients with Early Stage Lung Cancer
09:30 - 09:30 | Presenter: Erin Schenk | Author(s): J. Boland, S. Withers, P. Bulur, A. Dietz
- Abstract
Loading... -
+
P2.02-038 - Imaging Platform for the Quantification of Cell-Cell Spatial Organization within the Tumour-Immune Microenvironment
09:30 - 09:30 | Presenter: Katey S.S. Enfield | Author(s): S.D. Martin, Victor D Martinez, S.H.Y. Kung, P. Gallagher, K. Milne, Z. Chen, Stephen Lam, J.C. English, C.E. Macaulay, M. Guillaud, W.L. Lam
- Abstract
Loading... -
+
P2.02-039 - Spatial Heterogeneity of Immunological Markers Between Cores and Complete NSCLC Sections Using Multispectral Fluorescent IHC
09:30 - 09:30 | Presenter: Geoffrey Peters | Author(s): M. Ameratunga, D. Tutuka, M. Walkiewicz, Prudence Russell, S.R. Knight, P. Mitchell, T. John
- Abstract
Loading... -
+
P2.02-040 - Cytology Cell Block Is Suitable for Immunohistochemical Testing for PD-L1 in Lung Cancer
09:30 - 09:30 | Presenter: Hangjun Wang | Author(s): J. Agulnik, G. Kasymjanova, A.Y. Wang, V. Cohen, C. Pepe, D. Small, L. Sakr, P. Fiset, M. Auger, S. Camilleri-Broet, M. Alam Ei Din, A. Spatz
- Abstract
Loading... -
+
P2.02-041 - Update on Prospective Immunogenomic Profiling of Non-Small Cell Lung Cancer (ICON Project)
09:30 - 09:30 | Presenter: Jianjun Zhang | Author(s): B. Sepesi, I.P. Icon Team, Don Lynn Gibbons
- Abstract
Loading... -
+
P2.02-042 - Clinical Significance of the Tumor Expression of PD-L1 Using Four Immunohistochemistry Assays in Non-Small Cell Lung Cancer. Multicentre Study
09:30 - 09:30 | Presenter: Cristian Ortiz -Villalón | Author(s): A. Yoshikawa, L. Kis, A. Montero, Anja C Roden, H.H.N. Pham, C. Fernandez, J. Fukuoka, R. Lewensohn, L. De Petris
- Abstract
Loading... -
+
P2.02-043 - Multicentre Assessment of PD-L1 Immunohistochemistry: Challenges for Establishing the Concordance Between Four Different Antibodies
09:30 - 09:30 | Presenter: Cristian Ortiz -Villalón | Author(s): H.H.N. Pham, A. Yoshikawa, A. Montero, Anja C Roden, C. Fernandez, L. Kis, L. De Petris, J. Fukuoka
- Abstract
Loading... -
+
P2.02-044 - Pulmonary Findings in 7 Autopsy Cases of Patients Treated with Immune Checkpoint Inhibitors
09:30 - 09:30 | Presenter: Peter B Illei | Author(s): E.D. Thompson, J.M. Taube, J.E. Hooper, E. Rodriguez
- Abstract
Loading... -
+
P2.02-045 - PD-L1 Assessment in Cytology Samples
09:30 - 09:30 | Presenter: Peter B Illei | Author(s): A. Lerner, L. Yarmus
- Abstract
Loading... -
+
P2.02-046 - Assessment of PDL1 and Immunoprofiling Using Multiplex Quantitative Immunofluorescence in Lung Cancer: Clinical Implications
09:30 - 09:30 | Presenter: Vera Luiza Capelozzi | Author(s): Tabatha Gutierrez Prieto, C.A. Fahrat, T. Takagaki, J. Rodriguez-Canales, Ignacio I. Wistuba, E.R. Parra Cuentas
- Abstract
Loading... -
+
P2.02-047 - Comparison of PD-L1 Immunohistochemistry Assays and Response to PD-L1 Inhibitors
09:30 - 09:30 | Presenter: Sanja Dacic | Author(s): K. Ancevski, S. Aberrbock, C. Herbst, L. Villaruz
- Abstract
Loading... -
+
P2.02-048 - Survival Correlation Between TP53 Gene and PD-L1 Tumour Expression in Resected Non-Small Cell Lung Carcinoma
09:30 - 09:30 | Presenter: Jane Sze Yin Sui | Author(s): M.Y. Teo, S. Twomey, S. Rafee, J. McFadden, K. Gately, Martin P Barr, Steven G. Gray, B. Hennessy, Kenneth Obyrne, S. Cuffe, Stephen P Finn
- Abstract
Loading... -
+
P2.02-049 - Immunohistochemical Approach in Predicting Primary Lung Cancer Outcome: A Single Center Study
09:30 - 09:30 | Presenter: Gulrukh Komiljonovna Botiralieva | Author(s): M.N. Tillyashaykhov, A.A. Yusupbekov
- Abstract
Loading... -
+
P2.02-050 - Weighted Genes Co-expression Network Analysis of Lung Cancers Concerning Patients Overall Survival and Cancer Stage
09:30 - 09:30 | Presenter: Haolong Qi | Author(s): G.G. Chen
- Abstract
Loading... -
+
P2.02-051 - Bevacizumab Prevents Growth of Established Non-Small Cell Lung Cancer Brain Metastases in Hematogenous Brain Metastasis Model
09:30 - 09:30 | Presenter: Chinami Masuda | Author(s): M. Monnai, C. Ishimaru, R. Nakamura, M. Kinoshita, K. Yorozu, M. Kurasawa, M. Sugimoto, K. Yamamoto
- Abstract
Loading... -
+
P2.02-052 - A Clinically-Validated Universal Companion Diagnostic Platform for Cancer Patient Care
09:30 - 09:30 | Presenter: James Sun | Author(s): Y. Li, C. Milbury, J. Skoletsky, C. Burns, W. Yip, J. Luo, N. Dewal, A. Johnson, K. Gowen, J. Tong, Y. He, J. He, J. White, S. Roels, A. Tsuji, J. Truesdell, E. Peters, H. Gilbert, C. Wu, E. Schleifman, C. Barrett, K.S. Thress, S. Jenkins, J. Elvin, G. Otto, D. Lipson, Jeffrey S. Ross, V.A. Miller, P.J. Stephens, M. Doherty, C. Vietz
- Abstract
Loading... -
+
P2.02-053 - The Prognostic Value of 18 Circulating Markers of Inflammation, Endothelial Activation and
Extracellular Matrix Remodelling in Non-small Cell Lung Cancer Patients09:30 - 09:30 | Presenter: Janna Berg | Author(s): A.R. Halvorsen, M. Bengtson, K.A. Taskén, G. Mælandsmo, A. Yndestad, B. Halvorsen, O.T. Brustugun, P. Aukrust, T. Ueland, Å. Helland
- Abstract
Loading... -
+
P2.02-054 - Thymidylate Synthase Promotes Epithelial-To-Mesenchymal Transition and Aggressiveness in NSCLC
09:30 - 09:30 | Presenter: Paolo Ceppi | Author(s): A. Siddiqui, M.E. Vazakidou, A. Schwab, F. Napoli, I. Rapa, M. Volante, T. Brabletz
- Abstract
Loading... -
+
P2.02-055 - Stratifin Regulates Stabilization of Receptor Tyrosine Kinases via Activation of Ubiquitin-Specific Protease 8 in Lung Adenocarcinoma
09:30 - 09:30 | Presenter: Aya Shiba | Author(s): Y. Kim, M. Noguchi
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P2.02-057 - Expression of MGAT4a and MGAT5 Are Correlated with Poorer Outcome in Advanced Lung Adenocarcinoma
09:30 - 09:30 | Presenter: Yoko Nakanishi | Author(s): H. Nishimaki, I. Tsujino, N. Takahashi, M. Shimamura, H. Kobayashi, X.Y. Tang, Y. Kusumi, S. Hashimoto, S. Masuda
- Abstract
Loading... -
+
P2.02-058 - Endogenous Arginase 2 as a Biomarker for PEGylated Arginase 1 Treatment in Squamous Cell Lung Carcinoma Xenograft Models
09:30 - 09:30 | Presenter: Sze Kwan Lam | Author(s): Shi Xu, P.N. Cheng, J.C. Ho
- Abstract
Loading... -
+
P2.02-059 - Genomic Mutation Patterns Detected with Cancer Panel Can Predict Postoperative Prognosis in Clinical Stage I Adenocarcinoma
09:30 - 09:30 | Presenter: Kwanyong Hyun | Author(s): Y.J. Jung, S. Im, Y.H. Kim, S.B. Lee, S. Park, H.J. Lee, In Kyu Park, Chang Hyun Kang, Young Tae Kim
- Abstract
Loading... -
+
P2.02-060 - Prognostic Significance of EDIL3 Expression and Correlation with Mesenchymal Phenotype and Microvessel Density in Lung Adenocarcinoma
09:30 - 09:30 | Presenter: Young Wha Koh | Author(s): D. Jeong
- Abstract
Loading... -
+
P2.02-061 - Two Novel Protein-Based Prognostic Signatures Improve Risk Stratification of Early Lung ADC and SCC Patients
09:30 - 09:30 | Presenter: Luis M Montuenga | Author(s): E. Martinez-Terroba, C. Behrens, F. De Miguel, J. Agorreta, Eduard Monsó, L. Millares, M. Mesa-Guzman, J.L. Perez-Gracia, M.D. Lozano, Javier J. Zulueta, Ruben Pio, Ignacio I. Wistuba, M.J. Pajares
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P2.02-063 - Oncogenic microRNAs Associated with Poor Prognosis Are Up-Regulated on the Amplicon in Squamous Cell Lung Carcinoma
09:30 - 09:30 | Presenter: Sana Yokoi | Author(s): E. Xia, S. Kanematsu, Y. Suenaga, Y. Moriya, I. Yoshino, T. Iizasa
- Abstract
Loading... -
+
P2.02-064 - A Novel 5-miR Signature Shows Potential as a Diagnostic Tool and as a Predictive Biomarker of Cisplatin Response in NSCLC
09:30 - 09:30 | Presenter: Martin P Barr | Author(s): L. Mac Donagh, Steven G. Gray, M. Gallagher, B. Ffrench, C. Gasch, V. Young, R. Ryan, S. Nicholson, N. Leonard, Stephen P Finn, S. Cuffe, Kenneth Obyrne
- Abstract
Loading... -
+
P2.02-065 - RanBP9 is a Novel Prognostic and Predictive Biomarker for NSCLC and Affects Cellular Response to Cisplatin and PARP Inhibitors
09:30 - 09:30 | Presenter: Anna Tessari | Author(s): D. Palmieri, M. Pawlikowski, K. Parbhoo, C. Foray, M. Fassan, K. La Perle, E. Rulli, A. Fabbri, M. Ganzinelli, V. Embrione, M. Broggini, J.M. Amann, David P Carbone, Marina Chiara Garassino, C.M. Croce, V. Coppola
- Abstract
Loading... -
+
P2.02-066 - Identification of Crucial Gene Targets in the in Situ Environment of Cancer by Google Network Ranking
09:30 - 09:30 | Presenter: Victor Pontén | Author(s): M.W. Backman, Johanna Sofia Margareta Mattsson, Dijana Djureinovic, Patrick Micke
- Abstract
Loading... -
+
P2.02-067 - LKB1 Loss Is Associated with DNA Hypomethylation in Human Lung Adenocarcinoma
09:30 - 09:30 | Presenter: Michael John Koenig | Author(s): J.M. Amann, C. Oakes, J.M. Kaufman, David P Carbone
- Abstract
Loading... -
+
P2.02-068 - BRG1 and p53 Expression in Resected Stage I – III Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Gwyn Bebb | Author(s): A.A. Elegbede, M. Koebel, A. D'Silva, M. Dean, E. Enwere, R.A. Tudor, A.J.W. Gibson, H. Li, S. Otsuka
- Abstract
Loading... -
+
P2.02-069 - Targeting Neuropilin-1 in NSCLC
09:30 - 09:30 | Presenter: Martin P Barr | Author(s): G. Pidgeon, Steven G. Gray, K. Gately, E. Hams, P.G. Fallon, S. Cuffe, Stephen P Finn, Kenneth Obyrne
- Abstract
Loading... -
+
P2.02-070 - C-MET as a Biomarker in Patients with Surgically Resected Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Georgios Tsakonas | Author(s): Fred R. Hirsch, S. Ekman
- Abstract
Loading... -
+
P2.02-071 - Prospective Molecular Study of 22 Genes by NGS in Patients with Non-Small Cell Lung Cancer (NSCLC) in Argentina: A Single Institution Experience
09:30 - 09:30 | Presenter: Valeria Cecilia Denninghoff | Author(s): G.J. Recondo, M.T. Cuello, V. Romano, V. Wainsztein, F. Galanternik, M. Greco, M. De La Vega, M.A. Avagnina, G. Recondo
- Abstract
Loading... -
+
P2.02-072 - Reliability of Small Biopsy Samples for Tumor PD-L1 Expression in Non-Small-Cell Lung Cancer
09:30 - 09:30 | Presenter: Akihito Tsunoda | Author(s): K. Morikawa, M. Okamoto, T. Inoue, H. Kida, N. Furuya, H. Handa, H. Nishine, T. Inoue, T. Miyazawa, M. Mineshita
- Abstract
Loading... -
+
P2.02-073 - Cytoplasmic Mislocalization of ECT2 Protein Is Associated with Poor Prognosis in Lung Adenocarcinoma
09:30 - 09:30 | Presenter: Zeinab Kosibaty | Author(s): Y. Murata, Yuko Minami, S. Sakashita, M. Noguchi
- Abstract
Loading... -
+
P2.02-073a - Does the PD-L1 Status and TIL Intensity Change in NSCLC and Syncronous Brain Metastases?
09:30 - 09:30 | Presenter: Buge Oz | Author(s): S. Durak, S. Batur, Perran Fulden Yumuk, H.B. Caglar, E. Bozkurtlar, S. Bozkurt, E. Tastekin, I. Cicin, R. Ahıskalı, R. Rzazade, A. Cakır
- Abstract
Loading... -
+
P2.02-073b - Genetic Profile in NSCLC Biopsy Samples. A Muticenter Local Study
09:30 - 09:30 | Presenter: Norma Pilnik | Author(s): V. Bengio, M. Canigiani, P. Diaz
- Abstract
Loading...
-
+
P2.03 - Chemotherapy/Targeted Therapy
- 09:30 - 16:00
- 10/17/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Chemotherapy/Targeted Therapy
-
+
P2.03-001 - Survivors and Adverse Events After First-Line Target Therapy for Advanced Non-Small Cell Lung Cancer Patients in Taiwan
09:30 - 09:30 | Presenter: Lin Zhi Xuan | Author(s): C. Shu-Chan, H. Wen-Tsung
- Abstract
Loading... -
+
P2.03-002 - Impact of EGFR-Tyrosine Kinase Inhibitors for Postoperative Recurrent Non-Small Cell Lung Cancer Harboring EGFR Mutations
09:30 - 09:30 | Presenter: Satoshi Igawa | Author(s): Y. Sato, S. Kusuhara, S. Harada, M. Shirasawa, S. Kurahayashi, Y. Okuma, A. Sugimoto, K. Sugita, Y. Nakahara, S. Otani, T. Fukui, M. Yokoba, H. Mitsufuji, M. Kubota, M. Katagiri, J. Sasaki, N. Masuda
- Abstract
Loading... -
+
P2.03-003 - Cost Effectiveness of Gefitinib for Lung Adenocarcinoma Patients with Mutant Epidermal Growth Factor Receptor
09:30 - 09:30 | Presenter: Chun-Ru Chien | Author(s): T. Hsia, Chih-Yen Tu, H. Chen, S. Chen, C. Chen, W. Liao, C. Li, C. Lin, C. Li
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P2.03-005 - Overall Survival Results from a Prospective, Multicenter Phase II Trial of Low-Dose Erlotinib as Maintenance in NSCLC Harboring EGFR Mutation
09:30 - 09:30 | Presenter: Satoshi Hirano | Author(s): G. Naka, Y. Takeda, M. Iikura, T. Hiroishi, K. Shikano, A. Yanagisawa, N. Hayama, T. Fujita, H. Amano, M. Nakamura, S. Nakamura, H. Tabeta, H. Sugiyama
- Abstract
Loading... -
+
P2.03-006 - How Many Years of Life Have We Lost in Brazil Due to the Lack of Access to Anti-EGFR TKIs in the National Public Health System?
09:30 - 09:30 | Presenter: Pedro Aguiar Jr | Author(s): F. Roitberg, H. Tadokoro, R.A. De Mello, A. Del Giglio, Gilberto Lopes
- Abstract
Loading... -
+
P2.03-007 - Loxoprofen Prevents EGFR-TKI-Related Skin Rash in Non-Small Cell Lung Cancer Patients: A Single-Center Retrospective Study
09:30 - 09:30 | Presenter: Yohei Iimura | Author(s): H. Shimomura, K. Imanaka, Gaku Yamaguchi, N. Kawasaki, C. Konaka
- Abstract
Loading... -
+
P2.03-008 - Phase I/II Study of Intermitted Erlotinib in Combination with Docetaxel in Patients with Recurrent NSCLC with Wild-Type EGFR: WJOG 4708L
09:30 - 09:30 | Presenter: Tatsuo Kimura | Author(s): Tomoya Kawaguchi, S. Kudoh, Y. Chiba, H. Yoshioka, K. Watanabe, T. Kijima, Y. Kogure, T. Oguri, Naruo Yoshimura, T. Niwa, T. Kasai, Hidetoshi Hayashi, A. Ono, H. Tanaka, S. Yano, S. Nakamura, Nobuyuki Yamamoto, Yoichi Nakanishi, Kazuhiko Nakagawa
- Abstract
Loading... -
+
P2.03-009 - Clarification of Mechanisms of Acquired Resistance for Afatinib Using Plasma Samples
09:30 - 09:30 | Presenter: Tomomi Nakamura | Author(s): C. Nakashima, Kazutoshi Komiya, S. Kimura, Naoko Aragane
- Abstract
Loading... -
+
P2.03-010 - Updated Survival Outcomes of NEJ005/TCOG0902, a Randomized PII of Gefitinib and Chemotherapy in EGFR-Mutant NSCLC
09:30 - 09:30 | Presenter: Tatsuro Fukuhara | Author(s): S. Oizumi, S. Sugawara, K. Minato, T. Harada, A. Inoue, Y. Fujita, Satoshi Watanabe, K. Ito, Akihiko Gemma, Y. Demura, M. Harada, H. Isobe, I. Kinoshita, S. Morita, Kunihiko Kobayashi, K. Hagiwara, M. Kurihara, T. Nukiwa
- Abstract
Loading... -
+
P2.03-011 - Correlation and Problems of Re-Biopsy and Liquid Biopsy for Detecting T790M Mutation
09:30 - 09:30 | Presenter: Kazutoshi Komiya | Author(s): Tomomi Nakamura, M. Hayase, H. Hirakawa, S. Ogusu, Tomonori Abe, C. Nakashima, K. Takahashi, Y. Takeda, S. Kimura, N. Sueoka-Aragane
- Abstract
Loading... -
+
P2.03-012 - Characterization of the Efficacies of Osimertinib and Nazartinib against Cells Expressing Epidermal Growth Factor Receptor Mutations
09:30 - 09:30 | Presenter: Keita Masuzawa | Author(s): H. Yasuda, J. Hamamoto, I. Kawada, K. Naoki, K. Soejima, T. Betsuyaku
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P2.03-014 - A Phase I Study of Afatinib for Patients Aged 75 or Older with Advanced NSCLC Harboring EGFR Mutations
09:30 - 09:30 | Presenter: Hisashi Tanaka | Author(s): K. Baba, Y. Hasegawa, K. Taima, Y. Tanaka, M. Itoga, Y. Ishioka, T. Morimoto, H. Nakagawa, S. Takanashi, S. Tasaka
- Abstract
Loading... -
+
P2.03-015 - Efficacy of EGFR-TKIs for EGFR Mutatnt NSCLC Patients with Central Nervous System Metastases: A Retrospective Analysis
09:30 - 09:30 | Presenter: Kenichi Koyama | Author(s): Y. Saida, T. Abe, M. Satokata, Y. Mishina, K. Sato, Satoshi Shoji, T. Tanaka, K. Nozaki, K. Ichikawa, T. Miyabayashi, T. Ota, F. Fujimori, R. Ito, R. Kondo, T. Hiura, M. Okajima, S. Miura, Satoshi Watanabe, N. Matsumoto, H. Tanaka, T. Kikuchi
- Abstract
Loading... -
+
P2.03-016 - Clinical Utility of Liquid Biopsy for Detecting EGFR T790M Mutation Is Very Limited
09:30 - 09:30 | Presenter: Tomohiro Sakamoto | Author(s): Kohei Yamane, N. Tanaka, M. Yanai, H. Izumi, K. Yamaguchi, K. Takeda, H. Makino, T. Igishi, A. Yamasaki, E. Simizu
- Abstract
Loading... -
+
P2.03-017 - Clinical Features and Treatment with Afatinib in Patients with Squamous Cell Lung Cancer with Sensitive EGFR Mutations
09:30 - 09:30 | Presenter: Yuri Taniguchi | Author(s): A. Saihara, Y. Matsumoto, R. Furukawa, S. Ohara, A. Sato, M. Hojou, K. Usui
- Abstract
Loading... -
+
P2.03-018 - Diagnostic Yield of Fine-Needle Aspiration and Core-Needle Biopsy in Assessment of EGFR and ALK Mutation Status in Non–Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Junghoon Kim | Author(s): J. Kim
- Abstract
Loading... -
+
P2.03-019 - Sizing Capillary Electrophoresis with PCR to Detect Various EGFR Exon 19 Deletions in Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Eiji Nakajima | Author(s): M. Sugita, K. Furukawa, H. Takahashi, Y. Kawaguchi, Tatsuo Ohira, Norihiko Ikeda, Fred R. Hirsch, W.A. Franklin
- Abstract
Loading... -
+
P2.03-020 - Pemetrexed Continuation Maintenance versus Conventional Platinum-based Doublet Chemotherapy in EGFR-negative Lung Adenocarcinoma: Retrospective Analysis
09:30 - 09:30 | Presenter: Seung Hyeun Lee | Author(s): I.K. Hwang, S.S. Paik, M.J. Park
- Abstract
Loading... -
+
P2.03-021 - A Phase I Study Evaluating the Combination of Afatinib, Carboplatin and Pemetrexed after Failure of 1St Generation EGFR-TKIs
09:30 - 09:30 | Presenter: Ou Yamaguchi | Author(s): Satoshi Watanabe, A. Masumoto, Y. Maeno, Y. Kawashima, O. Ishimoto, S. Sugawara, H. Yoshizawa, Kunihiko Kobayashi, T. Nukiwa
- Abstract
Loading... -
+
P2.03-022 - Impact of EGFR Mutation on Clinical Outcome of Nintedanib plus Docetaxel in Previously Treated Non- Small Cell Lung Cancer (NSCLC)
09:30 - 09:30 | Presenter: Jin-Hyoung Kang | Author(s): S. Hong, H.J. Ahn, K..H. Kim, S.S. Lee, Y.G. Lee, Y.J. Yuh, P. I Cheon, Y.S. Chae, T.W. Jang
- Abstract
Loading... -
+
P2.03-023 - Characteristics of NSCLC Patients Treated in First Line Treatment with Tyrosine Kinase Inhibitors (TKI) - Real Data from the Czech Republic
09:30 - 09:30 | Presenter: Jana Skrickova | Author(s): R. Chloupkova, Z. Bortlicek, M. Pesek, V. Kolek, K. Hejduk, L. Koubkova, M. Cernovska, J. Krejci, M. Zemanová, L. Havel, J. Roubec, M. Hrnciarik, F. Salajka, H. Coupkova, M. Satankova, A. Benejova, I. Grygarkova, P. Opalka, D. Sixtova
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P2.03-025 - Prevalence of EGFR T790M Mutation in NSCLC Patients after Afatinib Failure, and Subsequent Response to Osimertinib
09:30 - 09:30 | Presenter: Maximilian Johannes Hochmair | Author(s): S. Schwab, O. Burghuber, R. Koger, U. Setinek, A. Cseh, R. Fritz, A. Buder, Martin Filipits
- Abstract
Loading... -
+
P2.03-026 - Managing EGFR T790M Mutation in Advanced Non-Small Cell Lung Cancers in THAILAND
09:30 - 09:30 | Presenter: Thongbliew - Prempree
- Abstract
Loading... -
+
P2.03-027 - Comparative Longitudinal Toxicity Analysis of EGFR Mutated NSCLC Treated with Either Pemetrexed Carboplatin or Gefitinib
09:30 - 09:30 | Presenter: Mansi Sharma | Author(s): Vijay Patil, A. Joshi, V. Noronha, A. Bhattarjee, S. Goud, S.B. More, A. Ramaswamy, A.P. Karpe, N. Pande, A. Chandrasekharan, Alok Goel, Vikas Talreja, K. Prabhash
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P2.03-029 - A Case of a Patient Harboring an EGFR Insertion of Exon 20 and Long Lasting Clinical Response to Afatinib
09:30 - 09:30 | Presenter: Ana Caroline Zimmer Gelatti | Author(s): V. Lorandi, G.D.S. Macedo, V.K. Gonçalves, R. Piccoli, S.D. Stefani
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P2.03-031 - Efficacy of Gefitinib and Radiotherapy Combination in Lung Adenocarcinoma
09:30 - 09:30 | Presenter: Elisna Syahruddin | Author(s): A.L. Huswatun, A. Prabowo, Sita Andarini, J. Zaini, A. Hudoyo, A. Jusuf
- Abstract
Loading... -
+
P2.03-032 - Efficacy and Safety of Osimertinib as Third-Line or Later Therapy for T790M-Positive Advanced Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Hiroyuki Shimada | Author(s): S. Endo, Y. Sasahara, T. Shinmura, T. Ozawa, H. Majima, T. Hara, Reina Imase, S. Yamauchi, Y. Sakakibara, A. Kobayashi, K. Yamazaki, Y. Jin, K. Yamanaka, O. Matsubara
- Abstract
Loading... -
+
P2.03-033 - Propensity Score-Adjusted Survival Analysis of Non-Small Cell Lung Cancer Patients with Acquired Resistance to EGFR-TKI
09:30 - 09:30 | Presenter: Sho Watanabe | Author(s): Y. Takeda, H. Kawamoto, S. Fujimoto, G. Naka, H. Sugiyama
- Abstract
Loading... -
+
P2.03-034 - EGFR Exon 19 Deletion Is Associated with Favorable Overall Survival After First-Line Icotinib Therapy in Advanced NSCLC Patients
09:30 - 09:30 | Presenter: Xiaochun Zhang | Author(s): C. Zhang, H. Hou, X. Cheng, D. Gong, H. Liu, H. Yu, W. Zhu, J. Zhu, K. Liu, H. Lv, N. Zhou, J. Cong, D. Liu, L. Yang, M. Jiang, Y. Zhang, L. Chen, Y. Zhu
- Abstract
Loading... -
+
P2.03-035 - Osimertinib in Relapsed EGFR-Mutated Non-Small Cell Lung Cancer Patients with Brain Metastases: Results from the TREM-Study
09:30 - 09:30 | Presenter: Inger Johanne Zwicky Eide | Author(s): Å. Helland, S. Borrisova, Simon Ekman, S. Cicenas, J. Koivunen, B.H. Grønberg, O.T. Brustugun
- Abstract
Loading... -
+
P2.03-036 - Comparing the Efficacy/Toxicity of Osimertinib and First Line EGFR-TKI by Individual Patient Analysis
09:30 - 09:30 | Presenter: Shoko Narita | Author(s): Yasushi Goto, J. Sato, R. Morita, S. Murakami, Shintaro Kanda, Hidehito Horinouchi, Y. Fujiwara, N. Yamamoto, Yuichiro Ohe
- Abstract
Loading... -
+
P2.03-037 - Osimertinib in Relapsed EGFR-Mutated, T790M-Negative Non-Small Cell Lung Cancer (NSCLC) Patients: Results from the TREM-Study
09:30 - 09:30 | Presenter: Inger Johanne Zwicky Eide | Author(s): Å. Helland, S. Borrisova, Simon Ekman, S. Cicenas, J. Koivunen, B.H. Grønberg, O.T. Brustugun
- Abstract
Loading... -
+
P2.03-038 - Early Serum Tumor Markers After 14 Days of Tyrosine Kinase Inhibitor Target Therapy Predicts Outcomes in Patients with Lung Adenocarcinoma
09:30 - 09:30 | Presenter: Kuo-Yang Huang | Author(s): H. Chen
- Abstract
Loading... -
+
P2.03-039 - Compassionate Use of Osimertinib: Argentine Experience
09:30 - 09:30 | Presenter: Jose Nicolas Minatta | Author(s): L. Lupinacci, G. Recondo, S. Sena, G. Boggio, A. Muggeri, C. Rosenbrock, F. Cayol, M. Angel, M. Muñoz, S. Berutti, N. Castagneris, D. Gomez Bradley, J.M. Lastiri
- Abstract
Loading... -
+
- Abstract
Loading... -
+
P2.03-041 - The Concentration of Avitinib in Cerebrospinal Fluid and Its Efficacy and Safety in NSCLC Patients with T790M Mutation
09:30 - 09:30 | Presenter: Hanping Wang | Author(s): L. Zhang, X. Zheng, X. Si, Xiaoxia Cui, M. Wang
- Abstract
Loading... -
+
P2.03-042 - EGFR Mutation and Erlotinib Efficacy in Turkish Oncoregistry
09:30 - 09:30 | Presenter: Mahmut Gumus | Author(s): M. Ozkan, U. Yilmaz, S.B. Tekin, C. Demir, A. Erdogan, Faysal Dane
- Abstract
Loading... -
+
P2.03-043 - A Phase 1b Study of Erlotinib and Momelotinib for TKI-Naïve EGFR-Mutated Metastatic Non-Small Cell Lung Cancer
09:30 - 09:30 | Presenter: Sukhmani Kaur Padda | Author(s): Karen L Reckamp, M. Koczywas, Joel W. Neal, J. Kawashima, S. Kong, Y. Xin, D. Huang, Heather A Wakelee
- Abstract
Loading... -
+
P2.03-044 - OSCILLATE - Phase 2 Trial of Alternating Osimertinib with Gefitinib in Patients with EGFR-T790M Mutation Positive Advanced NSCLC
09:30 - 09:30 | Presenter: Ben J Solomon | Author(s): P. Kok, A. Livingstone, S. Yip, C. Brown, S. Dawson, S. Wong, Nick Pavlakis, M. Stockler
- Abstract
Loading... -
+
P2.03-045 - Updated Results of Phase II, Liquid Biopsy Study in EGFR Mutated NSCLC Patients Treated with Afatinib (WJOG 8114LTR)
09:30 - 09:30 | Presenter: Hidetoshi Hayashi | Author(s): H. Akamatsu, Y. Koh, S. Morita, Daichi Fujimoto, Isamu Okamoto, A. Bessho, K. Azuma, Kazuhiko Nakagawa, Nobuyuki Yamamoto
- Abstract
Loading... -
+
P2.03-046 - Lymhocyte-To-Monocyte Ratio and Mean Platelet Volume as Prognostic Factor in EGFR Mutant NSCLC Treated with EGFR TKI
09:30 - 09:30 | Presenter: Kousuke Watanabe | Author(s): Y. Amano, H. Kage, Yasushi Goto, D. Takai, T. Nagase
- Abstract
Loading... -
+
P2.03-047 - The Main Treatment Failure Pattern for Completely Resected Stage II–IIIA (N1–N2) EGFR-Mutation Positive Lung Cancer
09:30 - 09:30 | Presenter: Songtao Xu | Author(s): W. Zhong, Y. Zhang, W. Mao, L. Wu, Y. Shen, Y. Liu, C. Chen, Ying Cheng, L. Xu, J. Wang, K. Fei, X. Li, J. Li, C. Huang, Z. Liu, S. Xu, K. Chen, S. Xu, L. Liu, P. Yu, B. Wang, H. Ma, H. Yan, X. Yang, Yi-Long Wu, Q. Wang
- Abstract
Loading... -
+
P2.03-048 - Mixed Response of Non-Small Cell Lung Cancer Harboring the EGFR T790M Mutation to Osimertinib
09:30 - 09:30 | Presenter: Yuki Shinno | Author(s): Yasushi Goto, J. Sato, R. Morita, Y. Matsumoto, S. Murakami, Shintaro Kanda, Hidehito Horinouchi, Y. Fujiwara, N. Yamamoto, Yuichiro Ohe
- Abstract
Loading... -
+
P2.03-049 - Pulmonary Adenoid Cystic Carcinoma with EGFR Activating Mutation and Responds Well with Tyrosine Kinase Inhibitor
09:30 - 09:30 | Presenter: Jamal Zaini | Author(s): Sita Andarini, Elisna Syahruddin, A. Hudoyo
- Abstract
Loading... -
+
P2.03-050 - The Efficacy of EGFR Tyrosine Kinase Inhibitors in Advanced Non-Small Cell Lung Cancer Harboring G719X Mutation
09:30 - 09:30 | Presenter: Hanping Wang | Author(s): L. Zhang, T. Lu, X. Zhang, Xiaoyan Si, M. Wang
- Abstract
Loading... -
+
P2.03-051 - The Impact of EGFR Mutations. Treatment with ITKs in Non Small Cell Lung Cancer Patients
09:30 - 09:30 | Presenter: Teresa García Manrique | Author(s): O. Saavedra, N. Palazón Carrión, C. Pérez Gago, J. Calvete, R. Carrillo, F.J. Valdivia García, D. Vicente Baz
- Abstract
Loading... -
+
P2.03-052 - Local Ablative Therapy for Oligoprogressive, EGFR-Mutant, Non-Small Cell Lung Cancer (NSCLC) After Treatment with Osimertinib
09:30 - 09:30 | Presenter: Udayan Guha | Author(s): C. Kim, N. Roper, C.D. Hoang, M. Connolly, C.M. Cultraro, E. Szabo, M. Waris, E. Padiernos, A.H. Kesarwala, S. Gao, S.M. Steinberg, D.T.W. Wong, J. Khan, A. Rajan
- Abstract
Loading... -
+
P2.03-053 - A Five-Year Audit of EGFR and ALK Testing at a Tertiary Care Centre in North India: More Sensitive Methods Do Make a Difference!
09:30 - 09:30 | Presenter: Valliappan Muthu | Author(s): A. Bal, N. Gupta, Kuruswamy Thurai Prasad, Digambar Behera, Navneet Singh
- Abstract
Loading... -
+
P2.03-054 - EGFR Mutation with Acquired C-MET Positive Reveals Potential Immunotherapeutic Vulnerabilities
09:30 - 09:30 | Presenter: Shan Su | Author(s): Z.Y. Dong, Jin -Ji Yang, X. Zhang, Z. Xie, J. Su, Z. Chen, Yi-Long Wu
- Abstract
Loading... -
+
P2.03-055 - Comparison of Afatinib Versus Erlotinib for Advanced Non-Small-Cell Lung Cancer Patients with Resistance to EGFR-TKI
09:30 - 09:30 | Presenter: Yuichi Sakamori | Author(s): Yuto Yasuda, Tomoko Funazo, T. Nomizo, T. Tsuji, Hironori Yoshida, H. Nagai, H. Ozasa, T. Hirai, Y.H. Kim
- Abstract
Loading... -
+
P2.03-056 - Primary Double EGFR Mutations T790M and Mutation in Exon 19 or 21 in Slovakian NSCLC Patients - Updated Survival Data
09:30 - 09:30 | Presenter: Peter Berzinec | Author(s): P. Kasan, R. Godal, L. Plank, L. Copakova, A. Alemayehu, G. Chowaniecova, A. Farkasova, P. Hlavcak, M. Kucma, L. Rotikova, M. Slavikova, P. Vasovcak
- Abstract
Loading... -
+
P2.03-057 - Effectiveness of Icotinib on Uncommon EGFR Exon 20 Insert Mutations: A763_Y 764insFQEA in Non-Small-Cell Lung Cancer
09:30 - 09:30 | Presenter: Meiyu Fang | Author(s): Chunwei Xu, W. Wang, Wu Zhuang, Z. Song, Rongrong Chen, Y. Guan, X. Yi, Gang Chen, T.F. Lv, Yong Song
- Abstract
Loading... -
+
P2.03-058 - Tiger-3: A Phase 3 Randomized Study of Rociletinib Vs Chemotherapy in EGFR-mutated Non-small Cell Lung Cancer (NSCLC)
09:30 - 09:30 | Presenter: James Chih-Hsin Yang | Author(s): Karen L Reckamp, Young-Chul Kim, Silvia Novello, Egbert F Smit, J. Lee, W. Su, W.L. Akerley, C. Blakely, Lyudmila A Bazhenova, R. Chiari, T. Hsia, T. Golsorkhi, D. Despain, D. Shih, L. Rolfe, Sanjay Popat, Heather A Wakelee
- Abstract
Loading... -
+
P2.03-058a - T790M-Selective EGFR-TKI Combined with Dasatinib as an Optimal Strategy for Overcoming EGFR-TKI Resistance in T790M-Positive NSCLC
09:30 - 09:30 | Presenter: Takeshi Yoshida | Author(s): S. Watanabe, H. Kawakami, N. Takegawa, Junko Tanizaki, Hidetoshi Hayashi, M. Takeda, Kimio Yonesaka, J. Tsurutani, Kazuhiko Nakagawa
- Abstract
No abstract available for this presentation
-
+
P2.04 - Clinical Design, Statistics and Clinical Trials
- 09:30 - 16:00
- 10/17/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Clinical Design, Statistics and Clinical Trials
-
+
P2.04-001 - BALTIC: A Phase 2, Open-Label Study of Novel Combinations of Immunotherapies or DDR Inhibitors in Platinum-Refractory ED-SCLC
09:30 - 09:30 | Presenter: Ihor Vynnychenko | Author(s): H. Jiang, Y. Huang, P.A. Dennis, J. Von Pawel
- Abstract
Loading... -
+
P2.04-002 - CASPIAN: Phase 3 Study of First-Line Durvalumab ± Tremelimumab + Platinum-Based Chemotherapy vs Chemotherapy Alone in ED-SCLC
09:30 - 09:30 | Presenter: Luis Paz-Ares | Author(s): H. Jiang, Y. Huang, P.A. Dennis
- Abstract
Loading... -
+
P2.04-003 - Phase II Trial of X-396 (Ensartinib) for Chinese Patients with ALK (+) Non–Small-Cell Lung Cancer Who Progressed on Crizotinib
09:30 - 09:30 | Presenter: Li Zhang | Author(s): Junling Li, W. Zhong, Y. Hu, X. Liu, Z. Wang, Y. Zhao, J. Feng, J. Zhou, Y. Zhang, Yun Fan, G. Wu, F. Tan, L. Ding
- Abstract
Loading... -
+
P2.04-004 - IMpower010: A Phase III Study of Atezolizumab vs Best Supportive Care Following Adjuvant Chemotherapy in Completely Resected NSCLC
09:30 - 09:30 | Presenter: Enriqueta Felip | Author(s): Heather A Wakelee, Eric Vallieres, Caicun Zhou, Y. Zuo, F. Xia, A. Sandler, Nasser Altorki
- Abstract
Loading... -
+
P2.04-005 - GEOMETRY Mono-1: Phase II, Multicenter Study of MET Inhibitor Capmatinib (INC280) in EGFR Wt, MET-Dysregulated Advanced NSCLC
09:30 - 09:30 | Presenter: Jürgen Wolf | Author(s): Ji-Youn Han, Makoto Nishio, P. Souquet, Luis Paz-Ares, F. De Marinis, Takashi Seto, M. De Jonge, T.M. Kim, Johan F. Vansteenkiste, Daniel SW Tan, Edward Brian Garon, H.J. Groen, Maximilian Johannes Hochmair, Enriqueta Felip, Noemi Reguart, M. Thomas, T.R. Overbeck, K. Ohashi, M. Giovannini, R. Yura, A. Joshi, M. Akimov, R. Heist
- Abstract
Loading... -
+
P2.04-006 - ADAURA: PhIII, Double-Blind, Randomized Study of Osimertinib vs Placebo in EGFR Mutation-Positive NSCLC Post-Tumor Resection
09:30 - 09:30 | Presenter: Roy S. Herbst | Author(s): Yi-Long Wu, H. Mann, Y. Rukazenkov, M. Marotti, M. Tsuboi
- Abstract
Loading... -
+
P2.04-007 - KEYNOTE-604: Phase 3 Randomized, Double-Blind Trial of Pembrolizumab/Placebo plus Etoposide/Platinum for Extensive Stage-SCLC
09:30 - 09:30 | Presenter: Charles M Rudin | Author(s): L. Shen, M.C. Pietanza
- Abstract
Loading... -
+
P2.04-008 - ATLANTIS: Phase III Study of PM01183 with Doxorubicin vs. CAV or Topotecan in Small-Cell Lung Cancer After Platinum Therapy
09:30 - 09:30 | Presenter: Jose Antonio Lopez-Vilariño | Author(s): A. Farago, Luis Paz-Ares, A. Fülop, A. Chiappori, K. Syrigos, C. Kahatt, G. Kos, A. Soto-Matos
- Abstract
Loading... -
+
P2.04-009 - Randomized, Single-Blind Phase 1 Study of Pharmacokinetic Equivalence of ABP 215 Relative to Bevacizumab in Japanese Subjects
09:30 - 09:30 | Presenter: Valdimir Hanes | Author(s): V. Chow, J. Pan, R. Markus
- Abstract
Loading... -
+
P2.04-010 - Afatinib in Combination with Pembrolizumab in Patients with Stage IIIB/IV Squamous Cell Carcinoma (SCC) of the Lung
09:30 - 09:30 | Presenter: Jonathan W Riess | Author(s): Jaafar Bennouna, Luis Paz-Ares, M.J. Chisamore, C. Lybeck Lind, B. Sadrolhefazi, B. Levy
- Abstract
Loading... -
+
P2.04-011 - The Using of LungCare Electromagnetic Navigated Bronchoscopy System in Lung Lesions, a New Project in China
09:30 - 09:30 | Presenter: Baohui Han | Author(s): S. Jiayuan, X. Zheng
- Abstract
Loading... -
+
P2.04-012 - First-Line Ensartinib (X396) versus Crizotinib in Advanced ALK-Rearranged NSCLC (eXalt3): A Randomized, Open-Label, Phase 3 Study
09:30 - 09:30